Resources
Healthcare

Public News Service: Virginia Forum Tackles Exploding Prescription Prices

Nov 25, 2019
Healthcare
In the News
Local Issues
Social Security, Medicare, & Retirement

PUBLIC NEWS SERVICE

No one should have to choose between food and medicine, and that crucial choice will be addressed at a public forum in Glen Allen on Tuesday on the exploding cost of prescription drugs.

The event will feature U.S. Rep. Abigail Spanberger, D-Virginia (7th District), taking public questions and comments about how people are dealing with these costs to help her inform her proposals for addressing the issue.

David DeBiasi, associate state director for advocacy with AARP Virginia, cosponsor of the event, said skyrocketing drug costs have hit folks in Virginia especially hard.

“Nearly a third of all Virginians have stopped taking a medicine as prescribed due to cost,” DeBiasi said. “And a kind of shocking fact: prices rose by nearly 60% between 2012 and 2017.”

He pointed out that during that same period, the annual income for Virginians only increased about 9%.

The forum will take place in the Glen Allen Branch Library from 4:00-5:00 p.m. More information is available on the AARP Virginia Facebook page.

DeBiasi said his organization is backing drug pricing legislation in Congress, including a bill introduced by House Speaker Nancy Pelosi that would allow some direct price negotiations between the government and pharmaceutical companies.

But with no guarantee anything will pass before year’s end, folks like Marlene Condon of central Virginia will continue to pay steep prices for medication. Condon said she’s struggled over the years to pay for her monthly prescriptions on a fixed income. One of the drugs she takes is a generic, but Condon said it still pricey.

“Even being on a prescription plan through insurance, I was still expected to pay hundreds of dollars for some of these drugs,” Condon said. “The hydroxychloroquine was over $500, and the methotrexate was over $200.”

She said she now only takes one of them, so her monthly expense is lower, but still costly. Rep. Spanberger’s bill to make drug-price negotiations more transparent and to lower costs recently passed the U.S. House with a unanimous vote. It now moves on for a Senate vote.

Recent Posts

Oct 11, 2024
Social Security, Medicare, & Retirement

NEW: Spanberger Pens Op-Ed Urging Colleagues to Vote to Pass Her Bipartisan Bill to Eliminate WEP & GPO

The Bipartisan “Social Security Fairness Act” Would Eliminate Two Provisions of the “Social Security Act” That Unfairly Reduce Benefits for Millions of Americans Who Have Devoted Much of Their Careers to Public Service Thanks to the Congresswoman’s Effort to Force a Vote on the Legislation, the “Social Security Fairness Act” Will Come to the U.S. […]

Oct 10, 2024
Energy & Environment

Spanberger Urges Speaker Johnson to Call U.S. House Back to Capitol Hill to Pass Emergency Appropriations Funding Following Hurricanes Helene & Milton

WASHINGTON, D.C. — U.S. Representative Abigail Spanberger is urging U.S. House Speaker Mike Johnson to call Members of Congress back to Capitol Hill to pass supplemental appropriations funds to support Virginia’s communities and communities across the Southeastern United State in the wake of Hurricanes Helene and Milton. In a letter to Speaker Johnson, Spanberger and […]

Oct 10, 2024
Good Governance

NEW: Spanberger Ranked #1 Most Collaborative Member of Congress from Virginia, #3 in the Country

An “A” Bridge Grade is Given to Members of Congress Who Exemplify Governing Behaviors that Bridge Our Country Rather than Divide It WOODBRIDGE, Va. — U.S. Representative Abigail Spanberger this week was ranked as the most collaborative Member of Congress from Virginia — and the third most collaborative lawmaker on Capitol Hill. Bridge Grades score […]